KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Sales (2016 - 2025)

Historic Return on Sales for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Sales rose 8800.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.14% for FY2024, which is 2000.0% down from last year.
  • Per Pacira BioSciences' latest filing, its Return on Sales stood at 0.03% for Q3 2025, which was up 8800.0% from 0.03% recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Return on Sales ranged from a high of 0.15% in Q2 2023 and a low of 0.85% during Q3 2024
  • Its 5-year average for Return on Sales is 0.0%, with a median of 0.05% in 2024.
  • In the last 5 years, Pacira BioSciences' Return on Sales tumbled by -9700bps in 2021 and then skyrocketed by 8800bps in 2025.
  • Pacira BioSciences' Return on Sales (Quarter) stood at 0.03% in 2021, then plummeted by -82bps to 0.06% in 2022, then soared by 334bps to 0.14% in 2023, then plummeted by -38bps to 0.09% in 2024, then tumbled by -65bps to 0.03% in 2025.
  • Its Return on Sales stands at 0.03% for Q3 2025, versus 0.03% for Q2 2025 and 0.03% for Q1 2025.